Literature DB >> 7483176

Polycythemia vera--a climatological disease.

N I Berlin1.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7483176      PMCID： PMC2376523     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN： 0065-7778


× No keyword cloud information.
  17 in total

1.  SURGERY IN POLYCYTHEMIA VERA.

Authors:  L R WASSERMAN; H S GILBERT
Journal:  N Engl J Med       Date:  1963-12-05       Impact factor: 91.245

2.  Recombinant interferon alpha in the treatment of polycythemia vera.

Authors:  E Cacciola; R Giustolisi; P Guglielmo; F Di Raimondo; E Cacciola; R D Calogero
Journal:  Blood       Date:  1991-06-15       Impact factor: 22.113

3.  Adverse effects of antiaggregating platelet therapy in the treatment of polycythemia vera.

Authors:  A P Tartaglia; J D Goldberg; P D Berk; L R Wasserman
Journal:  Semin Hematol       Date:  1986-07       Impact factor: 3.851

Review 4.  Structure, function, and activation of the erythropoietin receptor.

Authors:  H Youssoufian; G Longmore; D Neumann; A Yoshimura; H F Lodish
Journal:  Blood       Date:  1993-05-01       Impact factor: 22.113

5.  Life expectancy of patients with chronic nonleukemic myeloproliferative disorders.

Authors:  C Rozman; M Giralt; E Feliu; D Rubio; M T Cortés
Journal:  Cancer       Date:  1991-05-15       Impact factor: 6.860

6.  A new treatment for polycythemia vera: recombinant interferon alfa.

Authors:  R T Silver
Journal:  Blood       Date:  1990-08-15       Impact factor: 22.113

7.  Polycythemia vera: stem-cell and probable clonal origin of the disease.

Authors:  J W Adamson; P J Fialkow; S Murphy; J F Prchal; L Steinmann
Journal:  N Engl J Med       Date:  1976-10-21       Impact factor: 91.245

8.  Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy.

Authors:  P D Berk; J D Goldberg; M N Silverstein; A Weinfeld; P B Donovan; J T Ellis; S A Landaw; J Laszlo; Y Najean; A V Pisciotta; L R Wasserman
Journal:  N Engl J Med       Date:  1981-02-19       Impact factor: 91.245

9.  Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.

Authors:  P D Berk; J D Goldberg; P B Donovan; S M Fruchtman; N I Berlin; L R Wasserman
Journal:  Semin Hematol       Date:  1986-04       Impact factor: 3.851

10.  Treatment of polycythemia vera with hydroxyurea.

Authors:  P B Donovan; M E Kaplan; J D Goldberg; I Tatarsky; Y Najean; E B Silberstein; W H Knospe; J Laszlo; K Mack; P D Berk
Journal:  Am J Hematol       Date:  1984       Impact factor: 10.047
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.